[Diabetic cardiomyopathy: a focus on sodium-glucose cotransporter type 2 inhibitors]. [PDF]
Guerrero-Barrios S +5 more
europepmc +1 more source
[ROX index to predict failure with low flow devices in COVID-19]. [PDF]
Olivares-Melgoza FM +2 more
europepmc +1 more source
[Main clinical factors associated with hypoglycemia in patients with type 2 diabetes]. [PDF]
Sánchez-González BDC +6 more
europepmc +1 more source
COVID-19 and type 2 diabetes mellitus: implications in pancreatic beta cells. [PDF]
Sánchez-Cervantes IG +4 more
europepmc +1 more source
[Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19]. [PDF]
Carrasco-Sánchez FJ +7 more
europepmc +1 more source
[Comprehensive care of patients with type 1 diabetes in primary health care: policies, practices, and the role of civil societyAtenção integral a pacientes com diabetes tipo 1 na atenção primária à saúde: políticas, práticas e o papel da sociedade civil]. [PDF]
Rangel-Osuna F +2 more
europepmc +1 more source
Consequences of COVID-19 on people with diabetes. [PDF]
Bellido V, Pérez A.
europepmc +1 more source
[Severe diabetic ketoacidosis, acute kidney injury and dehydration due to canagliflozin in type 2 diabetes mellitus patient: Atypical clinical presentation]. [PDF]
Moreno Obregón F +3 more
europepmc +1 more source
[Phenotypic Classification of Diabetes: A Personalized Approach for Pharmaceutical Practice].
García Soláns J.
europepmc +1 more source

